Group 1 - The core business of the company is focused on the production and sales of functional toothpaste, which has seen significant growth due to increasing consumer awareness of oral health in China [2] - As of May 6, the company's stock price closed at HKD 0.060, a decrease of 6.25% from the previous trading day, with an intraday low of HKD 0.051, marking a new low for the past year [1] - The company ranked eighth in the Chinese functional toothpaste market and third in the leather care products market in 2015, indicating its competitive position within these sectors [1] Group 2 - The company has developed and patented the Fe biological enzyme technology for toothpaste production, which has been recognized as a national high-tech project by the Ministry of Science and Technology of China [2] - The functional toothpaste has been clinically tested and certified by various medical institutions, proving its effectiveness in preventing oral issues and ensuring safety for daily use [2] - The company launched the 'Fe Jindian Dentist' brand in 2012 to enhance the brand image of its functional toothpaste, reflecting its strategic marketing efforts [2]

Core Insights - The oral care market is evolving from basic products like toothpaste and toothbrushes to a diverse range of specialized products, including mouthwash, oral sprays, and advanced tools like electric toothbrushes and water flossers [1][4][18] - Consumers are increasingly focused on the efficacy of oral care products, emphasizing "maintenance," "treatment," and "aesthetic" functions when making purchasing decisions [2][7][10] Product Trends - The demand for advanced oral care products is rising, with significant sales growth in items like dental floss sticks (over 50% YoY) and tongue scrapers (over 100% YoY) [3][12] - Mouthwash has seen an 80% increase in search interest, particularly for probiotic, whitening, and portable options [5][18] - Whitening products, such as whitening strips and pens, have gained popularity, with search volumes increasing over 100% [6][18] Consumer Behavior - Over 90% of consumers switch oral care products within a year, with many using multiple types of toothpaste simultaneously to achieve different benefits [2][16] - There is a trend towards "personalized use," with 76% of families opting for separate toothpaste for different members, reflecting diverse oral care needs [16][17] - Consumers are increasingly aware of their oral health, with 93% reporting multiple oral issues, leading to a preference for products that address specific problems [10][18] Market Dynamics - The oral care market is shifting towards specialized products for specific demographics, such as children and the elderly, with significant sales growth in children's toothpaste and denture cleaning products [17][18] - The focus on aesthetics is driving demand for products that enhance appearance, with over 30% of consumers considering teeth as important for their overall attractiveness [3][12] - The market is witnessing a "micro smile competition," where keywords like "fresh breath," "whitening," and "ingredients" are becoming central to consumer choices [8][18]

内需美护板块推荐电话会议 20250428 • 预计登康口腔未来三年收入端复合增长率将超过 20%，利润端复合增长率 将超过 25%，在国产替代背景下，公司有望享受一定估值溢价。 • 中研股份和日丰股份是美护板块中值得关注的核心推荐企业，在母婴护理 领域具有较强竞争力，值得投资者密切跟踪。 20%。尤其是去年（2024 年）下半年至四季度，公司旗下卫生巾品牌奈斯公 主单月增速达到三倍以上，今年（2025 年）一季度这一趋势延续。 稳健医疗 公司的核心成长产品包括棉柔巾和卫生巾，这两类产品市占率提升空间大。在 渠道方面，电商增长拉动全面时代品牌发展，公司线上会员超过 1,400 万人， 为产品提供复购支持。此外，公司过去几年进行的消费者心智建设成效显著， 为未来增长奠定基础。 稳健医疗还收购了美国医疗耗材公司嘉里医疗，为海外 展业及关税优势打开空间。整体来看，公司通过双轮驱动模式实现增长：消费 品板块快速成长、医疗板块稳健发展。未来三年的利润复合增长预计超过 20%，体现出较大的收入端和利润率提升空间。这种高速成长对于如此大体量 的公司来说非常不易，因此估值也具有吸引力。 中港口腔公司的情况如何？ 对于中港口腔 ...

携手上千家齿科诊所，一场围绕儿童口腔健康的"专业下沉"正在全国展开。近日，国内儿童口腔护理品 牌兔头妈妈通过深度合作上千家齿科诊所，构建起"前端预防-中端干预-后端追踪"的全场景服务体系， 将儿童日常专业护齿理念输送至社区与家庭，为儿童龋齿防治提供创新范本。 据悉，兔头妈妈专注儿童防龋领域，其在2021年为国内首次引进进口奥拉氟，为国内儿童防蛀市场带来 变革，到2023年启动自研创新，目前取得多项相关科研成果，覆盖奥拉氟成分的制备、检测、及衍生物 的合成。2025年1月推出新一代高纯奥拉氟牙膏产品，将成果实现产品落地。 今年，兔头妈妈以"深度协同"为战略支点，与雅贝康、赛德阳光、极橙儿童齿科等全国头部连锁机构达 成合作，覆盖3000余家专业诊所，构建起"研发-验证-服务"一体化生态。这一布局不仅打通了产品从实 验室到终端的价值链路，更以技术壁垒重构行业竞争格局，为国货品牌突破国际巨头垄断提供了新范 式。 根据公开信息，兔头妈妈和齿科深度合作两年已久，齿科基本围绕社区展开，辐射周边社区，人群渗透 心智强。通过这一社区服务的优势，兔头妈妈协助齿科完成小小牙医、口腔义诊、育儿健康小课堂等 等，直接同用户沟通，加强健 ...

Core Viewpoint - The company is transitioning from a "small oral care" focus to a "large oral health" strategy, expanding its product and service offerings in the oral health sector, including smart oral care, oral beauty, and oral medical services [2][4]. Company Strategy and Product Development - The company is implementing a multi-brand and multi-category development strategy, with core brands including "Dengkang" and "Cold Acid Spirit," and plans to expand into four major business segments: oral care, oral medical, oral beauty, and oral capital management [3][4]. - In 2024, the company's revenue from oral medical and beauty care products increased by 35.45%, laying a solid foundation for entering the oral health industry [2]. Financial Performance - In 2024, the company achieved a revenue of 1.56 billion yuan, a year-on-year increase of 13.40%, and a net profit of 161 million yuan, up 14.07% [10]. - The company's gross profit margin for 2024 was 32%, an increase of 25 percentage points year-on-year, driven by product structure optimization, rapid online channel expansion, and improved production efficiency through smart factories [6]. Market Trends and Consumer Behavior - The oral care industry is experiencing a shift towards high-end and professional products, driven by increased consumer awareness of oral health and changing demographics [5]. - The rise of e-commerce and content-driven retail is reshaping consumer shopping habits, with traditional retail channels undergoing significant transformation [5]. Shareholder Returns and Corporate Governance - The company plans to distribute a cash dividend of 5 yuan per 10 shares for 2024, with a cash dividend rate of approximately 80%, reflecting its commitment to shareholder returns [9][10]. - The company emphasizes the protection of minority shareholders' rights and aims to enhance information disclosure and investor relations management [14]. Innovation and Technology - The company has developed unique dual sensitivity technology and bio-glass ceramic materials, which have been clinically validated to effectively address tooth sensitivity issues [15].

Group 1: Company Strategy and Market Position - The company aims to transition from "small oral care" to "large oral health" by expanding into smart oral care, oral beauty, and oral medical services, with a revenue growth of 35.45% in oral medical and beauty care products in 2024 [2][3] - The company employs a multi-brand strategy with core brands including "Dengkang" and "Cold Acid Spirit," targeting various consumer segments with a diverse product matrix [3] - The focus is on becoming a world-leading oral health expert, enhancing market share and competitiveness through a dedicated strategy in the oral health sector [3] Group 2: Industry Trends and Consumer Behavior - Rising awareness of oral health among consumers is driving demand for high-end and professional oral care products, with a shift towards rational and experiential consumption [4] - E-commerce channels are growing rapidly, while traditional retail is undergoing significant transformation, leading to increased competition in the market [4] Group 3: Financial Performance and Projections - The company reported a gross profit margin of 49.32% in 2024, an increase of 5.25 percentage points, driven by an optimized product mix and expansion in online sales [5] - The net profit growth of 27.07% in 2024 is attributed to increased sales scale and product upgrades [5] - Operating cash flow increased by 20.09% year-on-year, reflecting sustained growth in sales and net profit [5][8] Group 4: Shareholder Returns and Corporate Governance - The 2024 dividend plan proposes a payout of 7.5 CNY per 10 shares, with a cash dividend rate of approximately 80%, aligning with regulatory encouragement for higher investor returns [6] - The company emphasizes the protection of minority shareholders' rights and has consistently improved its dividend policy since listing [11] Group 5: Inventory and Supply Chain Management - Inventory increased by 15.64% in line with sales growth, indicating a healthy inventory turnover rate [8]

Core Viewpoint - The company reported a revenue of 1.56 billion yuan for 2024, representing a year-over-year increase of 13.4%, and a net profit attributable to shareholders of 160 million yuan, up 14.1% year-over-year, meeting expectations [1] Financial Performance - For Q4 2024, the company achieved a revenue of 510 million yuan, a year-over-year increase of 39.1%, with a net profit of 40 million yuan, up 28.6% year-over-year [1] - In Q1 2025, the company reported a revenue of 430 million yuan, a year-over-year increase of 19.4%, with a net profit of 40 million yuan, up 15.6% year-over-year [1] Product Category Performance - Adult toothpaste revenue reached 1.25 billion yuan, a year-over-year increase of 16.1%, with H1 and H2 growth rates of 7.0% and 24.4% respectively [2] - Adult toothbrush revenue was 160 million yuan, a year-over-year increase of 3.3%, with H1 and H2 growth rates of 0.6% and 6.1% respectively [2] - Oral medical and beauty care products generated 40 million yuan in revenue, a year-over-year increase of 35.5%, with H1 and H2 growth rates of -10.5% and +87.6% respectively [2] - Children's toothpaste and toothbrush revenues were relatively weak, at 70 million yuan and 30 million yuan respectively, with year-over-year changes of -0.5% and -5.1% [2] Sales Model Analysis - The distribution model generated 1.03 billion yuan in revenue, a year-over-year increase of 3.7%, accounting for 66% of total revenue [3] - The e-commerce model saw revenue of 480 million yuan, a year-over-year increase of 52.0%, accounting for 31% of total revenue [3] - The direct supply model reported revenue of 40 million yuan, a year-over-year decrease of 24.0% [3] Margin and Cost Analysis - The gross margin was 50.5%, an increase of 5.5 percentage points year-over-year, with H1 and H2 margins at 48.1% and 52.3% respectively [2] - The company’s gross margin, period expense ratio, and net profit margin for 2024 were 49.4%, 39.1%, and 10.3% respectively, showing year-over-year increases [3] Investment Outlook - The company is expected to continue benefiting from high-priced differentiated products driving e-commerce growth, which may enhance the willingness of offline distributors to stock higher-margin products [4] - Projected net profits for 2025-2027 are 210 million yuan, 240 million yuan, and 260 million yuan respectively, with year-over-year growth rates of 27.2%, 16.5%, and 10.5% [4]

Investment Rating - The report upgrades the company to a "Buy" rating, indicating an expected price increase of over 15% in the next 6-12 months [3][11]. Core Insights - The company reported a revenue of 1.56 billion RMB for 2024, a year-on-year increase of 13.4%, and a net profit of 161 million RMB, up 14.07% year-on-year, with a net profit margin of 10.33% [2]. - The growth is driven by the popularity of Douyin and the rapid expansion of key products, enhancing brand strength [2][3]. - The company is positioned as a leader in the sensitive oral care segment, leveraging product upgrades to increase customer spending and attract new customers [3]. Performance Analysis - For 2024, revenue from adult toothpaste, adult toothbrushes, children's toothpaste, children's toothbrushes, electric toothbrushes, and oral medical and beauty care products is reported as 1.247 billion, 161 million, 72 million, 30 million, 10 million, and 38 million RMB respectively, with growth rates of 16.09%, 3.30%, -0.48%, -5.09%, -14.33%, and +35.45% [2]. - The company achieved a gross margin of 49.37% in 2024, an increase of 5.27 percentage points year-on-year, driven by high-end product series [3]. - The sales expense ratio for 2024 is 31.96%, up 3.88 percentage points, primarily due to marketing efforts on platforms like Douyin [3]. Revenue and Profit Forecast - The company is expected to achieve net profits of 200 million, 258 million, and 332 million RMB for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 38.48, 29.78, and 23.17 [3][7]. - The projected revenue growth rates for the next few years are 27.91% for 2025, 20.88% for 2026, and 18.20% for 2027 [7]. Market Position - The company ranks third in retail market share for toothpaste products in offline sales channels, and its children's toothpaste and toothbrushes rank third and first in their respective categories [2]. - The company holds a 64.72% market share in the sensitive segment of offline retail [2]. Channel Performance - Revenue from distribution, direct supply, and e-commerce for 2024 is reported as 1.032 billion, 41 million, and 481 million RMB respectively, with year-on-year growth rates of 3.69%, -24.01%, and +51.99% [2]. - The introduction of the medical research 7-day repair series is expected to continue driving the trend of popular products across various channels [2].

Core Viewpoint - The company, Chongqing Dengkang Oral Care Products Co., Ltd., has released its 2024 annual report, highlighting its financial performance, operational strategies, and future development plans. Company Overview - The company is transitioning from a traditional manufacturing entity to a comprehensive solution provider, driven by innovations in biotechnology, artificial intelligence, cloud computing, big data, 5G, and the Internet of Things [4][12]. - The company emphasizes a dual-driven growth model combining organic growth and external expansion [4]. Financial Performance - For the year 2024, the company achieved a consolidated revenue of CNY 1,560,070,850.25, representing a year-on-year increase of 13.40% [34]. - The net profit attributable to shareholders was CNY 161,179,433.51, reflecting a growth of 14.07% compared to the previous year [34]. Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of CNY 7.50 per 10 shares, totaling CNY 129,130,350.00, with no bonus shares issued [24][25]. Research and Development - The company adopts a "marketing + R&D" dual-driven development strategy, focusing on market needs and maintaining a technology innovation system [5][7]. - It has established a collaborative innovation ecosystem with various universities and research institutions to enhance its technological capabilities [8]. Sales and Marketing Strategy - The company has developed a marketing network that includes distribution, direct supply, and e-commerce models, effectively reaching consumers across various channels [11][12]. - The strategy aims to enhance brand awareness and market penetration, supporting the growth of the oral health industry [12]. Governance and Compliance - The board of directors has ensured compliance with relevant laws and regulations, maintaining transparency and accountability in its operations [19][21]. - The company has also approved the continuation of its auditing firm, Xinyong Zhonghe, for the 2025 fiscal year [30].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001328证券简称：登康口腔公告编号：2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 （2022年修订）》（证监会公告〔2022〕15号）和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作（2023年12月修订）》（深证上〔2023〕1145号）的规 定，将本公司募集资金2024年度存放与使用情况专项说明如下： 一、 募集资金基本情况 （一） 实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次公开发行股票注册的 批复》（证监许可〔2023〕585号），本公司由主承销商中信建投证券股份有限公司采用网下向符合条 件的投资者询价配售及网上向持有深圳市场非限售A股股份和非限售存托凭证市值的社会公众投资者定 价发行相结合的方式，向社会公众公开发行人民币普通股（A股）股票4,304.35万股，发行价为每股人 民 ...